Episode 17

Episode 16. ASH 2022 Leukemia and Myeloid Malignancies Recap

Blood Cancer Talks · Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

February 25, 202355m 12s

Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Original episode page

Show Notes

1. Phase III ASAP trial

https://ash.confex.com/ash/2022/webprogram/Paper159962.html

2. Phase III Dauno-Double Trial

https://ash.confex.com/ash/2022/webprogram/Paper157126.html

3. Reduced venetoclax exposure:

https://ash.confex.com/ash/2022/webprogram/Paper165464.html

4. Menin Inhibitors in AML

https://ash.confex.com/ash/2022/webprogram/Paper164849.html

https://ash.confex.com/ash/2022/webprogram/Paper167412.html

5. Imetelstat in MDS: IMerge Phase 2

https://ash.confex.com/ash/2022/webprogram/Paper169050.html

6. MOMENTUM: Momelotinib

https://ash.confex.com/ash/2022/webprogram/Paper162783.html

How I manage anemia related to myelofibrosis and its treatment regimens

https://link.springer.com/article/10.1007/s00277-023-05126-4

Topics

HematologyCancer

← All episodes of Blood Cancer Talks